Replay available

National Health Investors, Inc. (NHI) Q1 2025 Earnings Call

National Health Investors, Inc. (NYSE: NHI) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.

Tue, May 6, 2025 at 11:00 AMendedReplay
National Health Investors, Inc. (NHI) Q1 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Dana Hambly

Vice President, Finance and Investor Relations

Eric Mendelson

President and CEO

Kevin Pascoe

Chief Investment Officer

John Spade

Chief Financial Officer

Juan Sanabria

Analyst, BMO Capital Markets

Rich Anderson

Analyst, Wedbush

Farol Granath

Analyst, Bank of America

Omotayo Okasanya

Analyst, Deutsche Bank

Austin Werschmitt

Analyst, KeyBank Capital Markets

Replay transcript excerpt

Welcome to National Health Investor's first quarter 2025 earnings webcast and conference call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. I will now turn the conference over to your host, Dana Hambly, Vice President, Finance and Investor Relations. You may begin. Thank you and welcome to the National Health Investors Conference Call to review results for the first quarter of 2025. On the call today are Eric Mendelson, President and CEO, Kevin Pascoe, Chief Investment Officer, John Spade, Chief Financial Officer, and David Travis, Chief Accounting Officer. The results as well as notice of the accessibility of this conference call were released after the market closed yesterday in a press release that's been covered by the financial media. Any statements in this conference call which are not historical facts are forward-looking statements. NHI cautions investors that any forward-looking statement may involve risks or uncertainties and are not guarantees of future performance. All forward-looking statements represent NHI's judgment as of the date of this conference call. Investors are urged to carefully review various disclosures made by NHI and its periodic reports filed with the Securities and Exchange Commission, including the risk factors and other information disclosed in NHI's Form 10-K for the year ended December 31, 2024, and Form 10-Q for the quarter ended March 31, 2025. Copies of these filings are available on the SEC's website at sec.gov or on NHI's website at nhireet.com. In addition, certain terms used in this call...

More from National Health Investors, Inc.